The existence of an autoimmune phenomenon in Chagas' disease has often been proposed, but it is only in the studies of Cossio et al. (1) and Santos-Buch and Texeira (6) that this hypothesis has received experimental support.
A fundamental aspect of this problem is the presence or absence of lymphocytes reactive to heart antigens and, consequently, able to participate in an autoimmune response such as that described in experimental myocarditis (3) .
In a previous communication (W. Mosca, J. Plaja, E. Gallardo, E. Rojas, and H. G. Barrios, Arch. Venez. Cardiol. 3:134, 1976) we have presented our preliminary data, and in this paper we report the capacity of lymphocytes of Chagasic patients to demonstrate proliferative responses when challenged with Trypanosoma cruzi or heart antigens.
MATERLALS AND METHODS
Selection of patients. Chagasic patients were divided into two groups. Group I was composed of 27 patients with a positive complement fixation reaction to T. cruzi antigens and suffering from Chagasic cardiomyopathy, defined according to criteria outlined in a previous communication (4) . Briefly, any other possible cause of heart disease was excluded. The patients were less than 45 years old and had one or both of the following electrocardiogram alterations: (i) complete right bundle branch block, plus anterior or posterior fascicular block of the left bundle; (ii) complete atrioventricular block with wide QRS complex. Group II consisted of 52 Chagasic patients without clinical evidence of heart disease, but with a positive complement fixation reaction to T. cruzi antigens. Group III was the control group. Basically, it was composed of 18 normal healthy individuals and 18 patients with heart disease, all of whom had a negative complement fixation reaction to Chagas' disease. A breakdown of the 18 patients with heart disease follows: coronary heart disease (recent myocardial infarction), 5 (ii) Antigen B. The same procedure as for antigen A was followed, except that the epimastigotes were freeze-thawed 10 times and centrifuged at 650 x g for 15 min. The Response to heart antigens. Positive SIs to heart antigens were obtained in 28.6% of the patients in group I, 25% in group II, and 0% in group III (Table 1 ). The higher incidence of reactivity in patients of groups I and II than in the controls was statistically significant. These findings are particularly relevant when it is considered that patients with different forms of nonChagasic cardiopathy were included in the control group to evaluate the presence of any nonspecific responses. 1.O SIs and net counts per minute against heart antigens were statistically significantly different when groups I and II were compared with group III (Table 2 ). No differences were found, however, when group I was compared with group II.
To detect whether there was a difference in reactivity to T. cruzi antigens between the patients with a positive SI against heart antigens and those in whom this was negative, these patients were separated within each group and then compared. No difference was found in group II, but in group I the reactivity to the T. cruzi antigens was significantly higher in the patients with a positive SI to heart antigens ( show a significant incidence of reactivity against heart antigens, not only in patients with Chagasic cardiomyopathy (group I), but also in those suffering from Chagas' disease in the absence of demonstrable heart involvement (group II); this contrasted with the non-reactivity of normal patients or controls with non-Chagasic cardiopathy (group III). We found no difference between the proportions in group I (28.5%) and group II (25%) having positive anti-heart reactivities. This finding could be used to argue that autosensitization is not related to cardiac disease; however, we feel that it is important to evaluate this observation closely. It appears, for example, that one fundamental need is to determine more precisely the clinical relevance of lymphocyte autosensitization, in a lungitudinal study, to correlate this reactivity with the pathogenic process of the disease. It should be noted that the majority of patients in group I (71%) did not demonstrate lymphoblastogenic responses to the heart antigens. In fact, in our studies we found a lower percentage of patients who were reactive to heart antigens than did Texeira et al. (8) . Those authors reported, using the leukocyte migration inhibition test with heart antigens, that all seven patients studied (two acute cases, two Chagasic cardiomyopathy patients, and three Chagasic patients without clinically apparent heart disease) were positive. This was interpreted as providing evidence for the presence of lymphocytemediated reactivity to heart antigens in all patients, irrespective of their clinical status. The difference between these results and ours may be due only to the small sample size used by Texeira et al.; however, it is also possible that the leukocyte migration inhibition test is more sensitive in detecting damage to the heart. It is also possible that its specificity for heart damage and its capacity to detect an active disease are low. This latter possibility is in agreement with the results of Wartenberg and Brostoff (10) , who showed that leukocyte migration inhibition with heart antigens in patients with coronary disease or myocardial infarction is positive and that this positivity persists long after infarction. The positive results were interpreted as being due to a response to heart damage and nonspecific for the heart; the heart fraction responsible for this reactivity was mitochondrial, and other tissue mitochondria produced the same response. It is therefore important to note that the heart fraction used by Texeira et al. also contains mitochondria (7). It should be stressed that, to eliminate any factor that could be attributed to a nonspecific response to tissue injury or other causes, we included patients with different types of heart disease, including myocardial infarction, in our control group. None of these was positive for the heart antigen used. Consequently, it is possible that lymphocyte proliferation measures a different parameter, or is more heart specific, than the leukocyte migration inhibition test and may reflect an active autoimmune process more than a past injury.
Texeira et al. (8) also evaluated the cytotoxic effect of lymphocytes against heart cells, but this was performed with a purified T-lymphocyte population, which may not have included a series of regulatory factors of the immune response (2) .
An interesting finding in our study was that the mean SI to T. cruzi antigens, although positive in both groups I and II, was higher in group I, suggesting a more intense immune response in patients with Chagasic cardiomyopathy. This observation, together with the higher net counts per minute to T. cruzi antigens in the patients with a positive SI to heart antigens in group I, is suggestive of the participation of the phenomenon of delayed hypersensitivity in the pathogenic process that produces Chagasic cardiomyopathy.
According to the reported data, lymphocyte blastogenesis could be a sensitive indicator of low-grade or incipient heart disease. Alternatively, lymphocyte blastogenesis to heart antigens may be irrelevant to the disease process.
It appears, therefore, that a significant percentage of Chagasic patients have positive lymphocyte blastogenesis to heart antigens; however, the significance of this response in the pathogenic process needs to be carefully assessed and defined in a longitudinal study.
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